Last week, the U.S. House of Representatives passed the 21st Century Cures Act with a vote of 392 to 26.
The Cures Act provides $6.3 billion in funding to federal agencies for the development of diagnostic tools, disease therapies and treatments, with $4.8 billion going to the National Institutes of Health to further the Precision Medicine Initiative, along with Vice President Joe Biden’s “Cancer Moonshot.”
In a statement, the House of Representatives said that:
The development of new drugs and devices is meaningless unless they are delivered to the right patients at the right time. Cures will help improve delivery by ensuring electronic health record systems are interoperable for seamless patient care and help fully realize the benefits of a learning health care system.
Despite the overwhelming support for the Act, there has been some criticism of the legislation. Prominent Sens. Bernie Sanders and Elizabeth Warren both opposed certain sections, pointing to further action that is necessary for much of the funding to come to fruition. However, the significant margin of victory suggests that the legislation will pass Senate approval.